𧬠ICD-10 CM E11.22 β Type 2 Diabetes Mellitus with Diabetic Chronic Kidney Disease
Billable Code Confirmed
ICD-10 CM E11.22 is a valid, billable 6-character ICD-10-CM code effective for FY2026. It is classified under Chapter 4 (Endocrine, Nutritional and Metabolic Diseases) within the E08-E13 diabetes mellitus block, under the E11 type 2 diabetes category, and E11.2- kidney complications subcategory. This code is a combination code that captures both type 2 diabetes mellitus AND diabetic chronic kidney disease in a single code β no separate standalone CKD causation code is required beyond the N18.x stage code. A βuse additional codeβ instruction in the Tabular mandates that N18.1-N18.6 be assigned alongside E11.22 to identify the specific CKD stage.
Non-Billable Parent Codes
- E11 (Type 2 diabetes mellitus) β Non-billable header category at 3 characters; requires a 4th, 5th, and in many cases 6th character specifying the complication or manifestation type. Assigning E11 alone is never valid for claim submission.
- E11.2 (Type 2 diabetes mellitus with kidney complications) β Non-billable 4-character subcategory; lacks the 5th/6th character specificity identifying the exact renal complication (nephropathy vs. diabetic CKD vs. other kidney complication). Further specificity is always required.
Clinical Context
ICD-10 CM E11.22 is used when a provider documents type 2 diabetes mellitus with diabetic chronic kidney disease (DKD) β a condition in which the kidneys have sustained progressive microvascular damage from chronic hyperglycemia, resulting in reduced GFR and/or elevated albuminuria that is attributed to the diabetes. Per ICD-10-CM Official Guideline I.C.4.a, when both diabetes and a condition that is commonly associated with diabetes are documented, a causal relationship is assumed (even without the word βdue toβ) β meaning if a patient has type 2 DM and CKD with no other documented cause for the CKD, E11.22 is the correct code without requiring the provider to explicitly write βdiabetic CKD.β However, if the provider documents a non-diabetic cause for the CKD, the diabetic CKD assumption does not apply and a separate CKD code with its identified etiology is used instead.
Code Classification
ICD-10 CM E11.22 is a diabetes mellitus combination diagnosis code β it is not a standalone CKD code, a hypertension code, or a nephrology-only code. It represents the intersection of type 2 diabetes and chronic kidney disease as an integrated clinical entity. The code requires a companion N18.x code per Tabular instruction and may require additional codes for hypertension (I12.x or I13.x), insulin use (Z79.4), and oral hypoglycemic drug use (Z79.84) to be fully compliant and clinically complete.
π Code Description
ICD-10 CM E11.22 classifies type 2 diabetes mellitus with diabetic chronic kidney disease (DKD) β formerly known as diabetic nephropathy in a broader sense, though ICD-10-CM now distinguishes the two. Diabetic kidney disease (DKD) encompasses the spectrum of renal damage caused by chronic hyperglycemia, including glomerulosclerosis, tubular injury, and progressive decline in GFR, resulting in CKD that is attributable to the diabetes. The combination code structure of E11.22 reflects ICD-10-CMβs design principle that diabetes complications are coded as a unified entity β the diabetes code captures both the underlying disease (type 2 DM) and the specific complication (CKD) without needing a separate βCKD due to diabetesβ code. Per the Tabular βuse additional codeβ instruction, E11.22 must always be accompanied by an N18.x code (N18.1-N18.6) identifying the specific chronic kidney disease stage; without the N18.x companion code, the coding is incomplete and does not reflect the full clinical picture for DRG, quality reporting, or risk adjustment purposes.
In the inpatient facility setting, E11.22 is one of the most frequently coded diabetes combination codes and is a high-priority HCC capture target in Medicare Advantage and risk-adjusted contracts. The code maps to HCC 37 (Diabetes with Chronic Complications) under CMS-HCC V28, carrying significantly higher RAF value than uncomplicated diabetes (HCC 38). When hypertension is also present β which is extremely common in patients with diabetic CKD β the guidelines require additional assignment of I12.9 (hypertensive CKD with stage 1-4 CKD) or I12.0 (hypertensive CKD with stage 5 CKD or ESRD) alongside E11.22 and N18.x, creating a mandatory three-code cluster for the full diabetic-hypertensive CKD picture. ESRD (N18.6) and dialysis status (Z99.2) must be added when documented, and insulin use (Z79.4) or oral hypoglycemic drug use (Z79.84) must be added per the E11 category-level βuse additional codeβ instruction.
π³ Code Tree / Hierarchy
E11 Type 2 diabetes mellitus β Non-billable
β
βββ E11.0 Type 2 DM with hyperosmolarity β Non-billable
β βββ E11.00 Without NKHHC coma β
Billable
β βββ E11.01 With coma β
Billable
β
βββ E11.1 Type 2 DM with ketoacidosis β Non-billable
β βββ E11.10 Without coma β
Billable
β βββ E11.11 With coma β
Billable
β
βββ E11.2 Type 2 DM with kidney complications β Non-billable
β βββ E11.21 Type 2 DM with diabetic nephropathy β
Billable
β βββ E11.22 Type 2 DM with diabetic chronic kidney disease β THIS CODE β
Billable
β β β οΈ USE ADDITIONAL CODE: N18.1-N18.6 (CKD stage)
β βββ E11.29 Type 2 DM with other diabetic kidney complication β
Billable
β
βββ E11.3 Type 2 DM with ophthalmic complications β Non-billable
β βββ (E11.311-E11.3599 β multiple laterality/macular edema variants)
β
βββ E11.4 Type 2 DM with neurological complications β Non-billable
βββ E11.5 Type 2 DM with circulatory complications β Non-billable
βββ E11.6 Type 2 DM with other specified complications β Non-billable
βββ E11.8 Type 2 DM with unspecified complications β
Billable
βββ E11.9 Type 2 DM without complications β
Billable
E11.22 vs. E11.21 β Which Renal Code to Use?
This is one of the most commonly debated distinctions in diabetes coding. Use E11.21 (diabetic nephropathy) when the provider specifically documents diabetic nephropathy β proteinuric kidney disease with Kimmelstiel-Wilson lesions or glomerulosclerosis. Use E11.22 when the provider documents diabetic chronic kidney disease or diabetic CKD with a documented stage. Per ICD-10-CM coding guidance and ICD10Monitor Coding Clinic commentary, if the provider documents CKD with a specific stage, E11.22 is more specific and preferred. Do NOT assign both E11.21 and E11.22 together β the Excludes 1 relationship prevents this. Query the provider if documentation is ambiguous between nephropathy and CKD.
Three-Code Cluster: E11.22 + N18.x + I12.x
When diabetes, CKD, and hypertension are all documented, ICD-10-CM requires three codes: E11.22 + N18.x (CKD stage) + I12.x or I13.x (hypertensive CKD). This is a mandatory coding cluster, not optional. The I12.x/I13.x code must reflect the same CKD stage as the N18.x code. Per guideline I.C.9.a, a presumptive causal relationship between hypertension and CKD is assumed unless documented otherwise β so even if the provider says βCKD in a hypertensive patient with diabetes,β all three codes apply without requiring explicit βdue toβ language.
β Includes
- Type 2 DM with diabetic CKD, any stage (N18.1-N18.6): E11.22 covers diabetic CKD from Stage 1 through ESRD; the specific stage is captured in the required companion N18.x code, not within E11.22 itself.
- Diabetic kidney disease (DKD) β Type 2: The clinical term βdiabetic kidney diseaseβ or βDKDβ in provider documentation maps to E11.22 + N18.x when a CKD stage is documented.
- Type 2 DM with CKD and ESRD: When the patient has progressed to ESRD (N18.6) as a diabetic complication, E11.22 + N18.6 is the correct code pair; Z99.2 (dialysis dependence) and I12.0 (hypertensive CKD with ESRD) are added as applicable.
- Type 2 DM with CKD and kidney transplant history: E11.22 + N18.x + Z94.0 (transplant status) is the correct cluster when a post-transplant patient retains CKD attributable to prior diabetic damage.
- Undocumented diabetes type defaults to Type 2: Per ICD-10-CM Guideline I.C.4.a, if the type of diabetes is not documented and the patient has CKD, the default is type 2 diabetes β E11.22 is assigned even without explicit βtype 2β documentation.
β Excludes
Excludes 1
These codes represent mutually exclusive conditions β do not assign with E11.22:
- ICD-10 CM E11.21 β Type 2 diabetes mellitus with diabetic nephropathy: E11.21 and E11.22 represent distinct (though clinically overlapping) renal complications of type 2 diabetes and cannot be coded together for the same encounter. E11.21 is appropriate when the provider documents diabetic nephropathy (proteinuric kidney disease, Kimmelstiel-Wilson, glomerulosclerosis) without explicit CKD staging. E11.22 is preferred when the provider documents diabetic CKD with a specific stage. If the provider documents both terms in the same note, assign the code that best reflects the more specific, documented condition β typically E11.22 when a CKD stage is present. Per ICD10Monitor Coding Clinic commentary, it would be redundant to assign both, and E11.22 is considered more specific when CKD staging is documented.
E11.21 vs. E11.22 β The Most Common Diabetes-Renal Coding Error
Assigning both E11.21 and E11.22 for the same encounter is a direct Excludes 1 violation and the most common compliance error in diabetic renal complication coding. It also generates claim edits and rejection in many payer systems. When provider documentation contains both terms (βdiabetic nephropathyβ and βCKD stage 3β), a CDI query is appropriate to clarify which best describes the patientβs renal disease β or, if CKD staging is present, default to the more specific E11.22. Never assign both codes simultaneously.
Excludes 2
These conditions are not included in E11.22 but must be coded additionally when documented:
- I12.9 / I12.0 β Hypertensive chronic kidney disease: When hypertension coexists with diabetic CKD, ICD-10-CM guidelines require both E11.22 and the appropriate I12.x code (I12.9 for stages 1-4, I12.0 for stage 5/ESRD). The causal relationship between hypertension and CKD is assumed per Guideline I.C.9.a. Omitting I12.x when hypertension is documented alongside diabetic CKD is one of the most common and HCC-impactful coding omissions in this patient population.
- I13.x β Hypertensive heart and chronic kidney disease: When heart failure, hypertension, and CKD are all documented together alongside diabetes, I13.x replaces I12.x in the coding cluster β E11.22 + I13.x + N18.x + the heart failure code.
- Z99.2 β Dependence on renal dialysis: Must be coded additionally when the patient is dialysis-dependent; dialysis status is not captured within E11.22 or N18.6 alone.
- Z94.0 β Kidney transplant status: Must be coded additionally when the patient has a history of kidney transplant and retains residual CKD post-transplant.
π Clinical Overview
E11.22 Code Clustering: Required Companion Codes
ICD-10 CM E11.22 cannot stand alone as a clinically complete coding representation. The Tabular βuse additional codeβ instruction and ICD-10-CM diabetes/CKD/hypertension guidelines create mandatory code clusters that coders must apply whenever documented. Understanding the full required code set is essential for compliance, accurate DRG weight, and complete HCC capture.
| Clinical Scenario | E11.22 | N18.x Required? | I12.x/I13.x Required? | Z79.4 or Z79.84? | Z99.2? |
|---|---|---|---|---|---|
| T2DM + CKD Stage 3 only | β | N18.30 or N18.31/N18.32 | No (if no HTN documented) | Per medication documentation | No |
| T2DM + CKD Stage 3 + HTN | β | N18.30-N18.32 | I12.9 required | Per medication documentation | No |
| T2DM + CKD Stage 4 + HTN + insulin | β | N18.4 | I12.9 required | Z79.4 required | No |
| T2DM + ESRD + HTN + dialysis | β | N18.6 | I12.0 required | Per medication documentation | Z99.2 required |
| T2DM + ESRD + HTN + HF | β | N18.6 | I13.11 or I13.2 required | Per medication documentation | Z99.2 if dialysis |
CDI Trigger β CKD Stage Documentation
The single most high-yield CDI intervention for E11.22 encounters is ensuring the provider explicitly documents the CKD stage (1 through 5, or ESRD) using the N18 classification scale. Coders cannot infer the CKD stage from eGFR lab values alone β the provider must document the stage. When lab results indicate a GFR consistent with Stage 3 but the providerβs note only says βCKDβ or βkidney disease,β a CDI query for stage specificity is warranted and will ensure the correct N18.x code is assigned, which directly impacts DRG tier (Stage 4/5/ESRD = CC or MCC) and downstream quality reporting. Similarly, confirm whether insulin, oral hypoglycemic drugs, or both are in use β these require separate Z79.x codes per E11 category-level βuse additional codeβ instruction.
Manifestations & Symptom Burden
- Proteinuria/Albuminuria: A hallmark early manifestation of diabetic kidney disease; when documented separately, R80.x (proteinuria) may be coded as an additional diagnosis.
- Anemia of CKD: Patients with advanced diabetic CKD frequently develop renal anemia; when documented, D63.1 (anemia in chronic kidney disease) is separately codeable and may qualify as a CC, impacting DRG tier.
- Hyperkalemia: A common electrolyte complication of CKD Stages 3b-5; when documented, E87.5 (hyperkalemia) is separately codeable and may carry CC weight.
- Metabolic Acidosis: Advanced CKD-associated metabolic acidosis; when documented, E87.2 (acidosis) is separately codeable and may qualify as MCC in certain DRG scenarios.
- Secondary Hypertension from CKD / Volume Overload: Fluid retention and hypertension exacerbation are common in advanced diabetic CKD; documentation of hypertensive urgency, heart failure exacerbation, or volume overload should trigger additional code assignment and CDI queries for specificity.
Manifestation Coding and DRG Optimization
ICD-10 CM [E11.22]] encounters are rich with legitimate, documentable secondary diagnoses that directly elevate DRG weight. Anemia of CKD (D63.1 β CC), hyperkalemia (E87.5 β CC), metabolic acidosis (E87.2 β MCC in some scenarios), and heart failure (I50.xx β MCC) are all commonly present but frequently undercoded in diabetic CKD inpatient encounters. Thorough review of the H&P, labs, and nursing notes for documented conditions, combined with targeted CDI queries for provider linkage, is the highest-yield activity in optimizing these encounters. Never infer diagnoses from labs alone β the provider must document the clinical correlation.
π° HCC Risk Adjustment
| HCC Model | HCC Category | RAF Value (Community Non-Dual Aged) | Notes |
|---|---|---|---|
| CMS-HCC V28 (PY2026) | HCC 37 β Diabetes with Chronic Complications | ~0.166 | Fully implemented PY2026 |
| CMS-HCC V28 (PY2026) | HCC 329 β CKD Stage 3 (if N18.30/N18.31/N18.32 also coded) | Additional RAF | N18.3x adds HCC 329 value |
| CMS-HCC V28 (PY2026) | HCC 328 β CKD Stage 4 (if N18.4 coded) | Higher additional RAF | N18.4 adds HCC 328 |
| CMS-HCC V28 (PY2026) | HCC 326 β End Stage Renal Disease (if N18.6 coded) | Highest additional RAF | ESRD is highest-weight CKD HCC |
| CMS-HCC V24 (legacy, phased out 2026) | HCC 18 β Diabetes with Chronic Complications | ~0.368 (V24 scale) | V24 fully replaced by V28 PY2026 |
ICD-10 CM E11.22 is one of the most HCC-impactful diabetes codes under CMS-HCC V28, mapping to HCC 37 (Diabetes with Chronic Complications) with an approximate RAF value of 0.166 for the community non-dual aged population β significantly higher than uncomplicated diabetes at HCC 38. Critically, the required companion code N18.x also generates its own HCC mapping: N18.3 β HCC 329, N18.4 β HCC 328, N18.5 β HCC 327, and N18.6 (ESRD) β HCC 326, which carries the highest weight. This means that properly coding the CKD stage alongside E11.22 produces two separate HCC contributions β one from the diabetic complication (HCC 37) and one from the CKD stage (HCC 328/329/326 etc.) β making complete N18.x stage coding a critical double-RAF capture opportunity. Annual documentation of both the active diabetic CKD diagnosis and the current CKD stage is essential to prevent RAF score attrition in Medicare Advantage; if either is not documented in a given calendar year, one or both HCC captures are lost.
π₯ MS-DRG Assignment
ICD-10 CM E11.22 as a principal diagnosis routes to MDC 10 β Endocrine, Nutritional and Metabolic Diseases and Disorders, DRG 637/638/639 (Diabetes). DRG tier depends on the CC/MCC status of secondary diagnoses.
| Clinical Scenario | Principal Dx | Key Secondary Dx | DRG | Notes |
|---|---|---|---|---|
| T2DM with CKD Stage 3, HTN controlled | E11.22 | N18.30, I12.9 β N18.30 may not carry CC | DRG 639 or 638 | Stage 3 CKD may carry CC depending on version |
| T2DM with CKD Stage 4, HTN | E11.22 | N18.4, I12.9 β N18.4 = CC | DRG 638 | Stage 4 CKD = CC β DRG 638 |
| T2DM with CKD Stage 5/ESRD | E11.22 | N18.6, I12.0, Z99.2 β N18.6 = MCC | DRG 637 | ESRD = MCC β highest tier DRG 637 |
| T2DM with CKD + anemia of CKD | E11.22 | D63.1 β CC | DRG 638 | Anemia of CKD adds CC when Stage 3 present |
| T2DM DKA as reason for admit | E11.10 | E11.22 as secondary | DRG 637 or 638 | DKA principal; E11.22 secondary CC contribution |
When E11.22 is the principal diagnosis, the N18.x stage code directly determines whether the case clears the CC threshold: N18.4 (Stage 4) and above typically generate CC or MCC designations that elevate the DRG. Advanced CKD with ESRD (N18.6) frequently qualifies as MCC, pushing the case to DRG 637 β the highest-weight tier. Coders must identify all secondary diagnoses contributing CC/MCC status to avoid leaving the encounter in the lower-weight DRG 639 (without CC/MCC). Anemia of CKD (D63.1 β CC), heart failure (I50.xx β MCC), metabolic acidosis (E87.2 β potential MCC), and hyperkalemia (E87.5 β CC) are commonly present but frequently missed secondary codes in these encounters.
π Related ICD-10-CM Codes
E11 Diabetic Renal Complication Spectrum:
- E11.21 β Type 2 DM with diabetic nephropathy (Excludes 1 with E11.22 β do not use both)
- E11.29 β Type 2 DM with other diabetic kidney complication (e.g., renal tubular degeneration)
- E10.22 β Type 1 diabetes mellitus with diabetic chronic kidney disease (same concept, Type 1)
Required Companion Codes (N18 Series β CKD Stage):
- N18.1 β CKD Stage 1 (GFR β₯ 90, kidney damage markers present)
- N18.2 β CKD Stage 2 (GFR 60-89)
- N18.30 β CKD Stage 3 unspecified; N18.31 β Stage 3a (GFR 45-59); N18.32 β Stage 3b (GFR 30-44)
- N18.4 β CKD Stage 4 (GFR 15-29) β CC level
- N18.5 β CKD Stage 5 (GFR < 15, pre-dialysis)
- N18.6 β End Stage Renal Disease (ESRD, dialysis-dependent) β MCC level
Hypertension + CKD Codes (Required When HTN Documented):
- I12.9 β Hypertensive CKD with Stage 1-4 CKD or unspecified CKD
- I12.0 β Hypertensive CKD with Stage 5 CKD or ESRD
- I13.10 β Hypertensive heart and CKD with heart failure and Stage 1-4 CKD
- I13.2 β Hypertensive heart and CKD with heart failure and Stage 5/ESRD
Medication/Status Add-On Codes (Required When Documented):
- Z79.4 β Long-term current use of insulin
- Z79.84 β Long-term current use of oral hypoglycemic drugs
- Z99.2 β Dependence on renal dialysis (ESRD patients)
- Z94.0 β Kidney transplant status
π οΈ Commonly Associated CPT Codes
-
99232 / 99233 β Subsequent hospital care (moderate/high complexity): Inpatient E&M codes for daily management of diabetic CKD patients. The complexity of managing diabetic CKD β medication adjustments, fluid/electrolyte management, renal dosing of medications β strongly supports high-complexity MDM. E11.22 in the problem list contributes to medical necessity documentation for high-complexity subsequent care codes. When nephrology is also managing the patient, separate consultation or subsequent care codes may be billed under co-management rules.
-
90935 / 90937 β Hemodialysis procedure: When E11.22 is paired with N18.6 (ESRD) and Z99.2 (dialysis dependence), hemodialysis procedure codes become relevant for the professional fee side. 90935 covers a single evaluation with dialysis; 90937 covers repeated evaluation. On the inpatient facility side, dialysis is captured with the appropriate ICD-10-PCS performance/extracorporeal assistance code.
-
90945 / 90947 β Peritoneal dialysis procedure: For ESRD patients managed with peritoneal dialysis (PD) rather than hemodialysis. PD is increasingly used in diabetic ESRD; the distinction between HD and PD affects both the CPT code selection and the PCS procedure code. Z49.02 (encounter for peritoneal dialysis) should accompany these codes when the dialysis encounter is the primary reason for admission.
-
99291 / 99292 β Critical care time codes: When advanced diabetic CKD precipitates critical illness (e.g., hyperkalemia-induced arrhythmia, uremic encephalopathy, sepsis with acute-on-chronic kidney failure), critical care time codes may be appropriate for the professional fee encounter. E11.22 + N18.x + the acute complication codes provide the medical necessity foundation.
-
80048 β Basic metabolic panel (BMP): Routine laboratory monitoring of diabetic CKD patients includes BMP for electrolytes, BUN, creatinine, and glucose. This is the cornerstone monitoring CPT code billed alongside E11.22 and N18.x in outpatient/office follow-up β on the inpatient facility side, labs are included in the DRG payment.
-
88300 series / Kidney biopsy pathology β 88307: When kidney biopsy is performed to distinguish diabetic nephropathy from other CKD etiologies (particularly when the CKD pattern is atypical for diabetes), biopsy pathology codes are relevant. The biopsy result may change the coding from E11.22 to a non-diabetic CKD code depending on findings.
NCCI Bundling Considerations
For dialysis procedure codes (90935, 90937, 90945), NCCI edits govern the relationship between dialysis E&M and other same-day E&M services β generally, the dialysis procedure code includes a significant E&M component, and separate E&M billing on the same date requires documentation of a separately identifiable problem unrelated to the dialysis management. BMP (80048) bundles into comprehensive metabolic panel (80053) when both are ordered on the same date β only the comprehensive panel should be billed if both are ordered. Kidney biopsy pathology codes (88307) bundle with the physician interpretation code and should not be double-billed.
π¬ ICD-10-PCS Crosswalk
E11.22 is an ICD-10-CM diagnosis code. The following ICD-10-PCS codes are commonly assigned in inpatient encounters where E11.22 is the principal or secondary diagnosis:
-
5A1D70Z β Performance of Urinary Filtration, Intermittent, Less than 6 Hours Per Day: The ICD-10-PCS code for intermittent (conventional) hemodialysis. When ESRD patients (E11.22 + N18.6) undergo inpatient hemodialysis, this PCS code is assigned as an additional procedure. Accurate Root Operation (Performance), Body System (Urinary), and duration character selection are required for PCS compliance.
-
5A1D80Z β Performance of Urinary Filtration, Prolonged Intermittent, 6-18 Hours Per Day: Represents prolonged intermittent renal replacement therapy (PIRRT) β used for critically ill patients with acute-on-chronic kidney failure. This is distinct from conventional HD; the duration character distinguishes the modalities in PCS.
-
5A1D90Z β Performance of Urinary Filtration, Continuous, Greater than 18 Hours Per Day: Continuous renal replacement therapy (CRRT) β used in ICU settings for hemodynamically unstable patients. When a patient with E11.22 + advanced CKD develops acute kidney failure requiring CRRT, this PCS code applies.
-
0TY00Z0 / 0TY10Z0 β Transplantation of Kidney (allograft): Kidney transplantation for ESRD secondary to diabetic CKD is coded with the appropriate transplantation PCS code (right or left kidney). This is the highest-acuity renal procedure in the diabetic CKD pathway and drives the encounter to the kidney transplant DRG (DRG 652/653/654), which carries the highest relative weight in the MDC 11 surgical pathway.
π Coding Scenarios and Examples
Scenario 1 β T2DM with CKD Stage 3b, Hypertension, Insulin-Dependent
A 71-year-old male with type 2 diabetes mellitus (insulin-dependent), CKD Stage 3b attributed to diabetic kidney disease, and essential hypertension was admitted for hypoglycemia management and electrolyte correction. Discharge summary documented: βType 2 diabetes mellitus with diabetic CKD, Stage 3b; hypertension; insulin-dependent diabetes.β
Correct Coding:
- Principal Dx: E11.22 β Type 2 DM with diabetic chronic kidney disease
- Additional: N18.32 β CKD Stage 3b (GFR 30-44)
- Additional: I12.9 β Hypertensive CKD with stage 1-4 CKD
- Additional: Z79.4 β Long-term current use of insulin
- Additional: E11.649 β Type 2 DM with hypoglycemia without coma (if hypoglycemia was the admission driver β may be principal instead)
Sequencing Note: If hypoglycemia was the primary condition chiefly responsible for admission, E11.649 may be sequenced as principal per UHDDS, with E11.22 as additional. Confirm with clinical context.
CDI Note: Stage 3b (N18.32) may not carry CC weight on its own β confirm the CC/MCC table. Query for any anemia of CKD (D63.1 β CC) that may be present given the GFR level. The I12.9 code is mandatory given documented hypertension; omitting it is one of the top audit findings in this code cluster.
Scenario 2 β T2DM with CKD Stage 4, HTN, Anemia of CKD
A 68-year-old female with type 2 diabetes mellitus (oral metformin), CKD Stage 4 attributed to diabetic kidney disease, essential hypertension, and documented anemia of chronic kidney disease was admitted for anemia management and nephrology consultation.
Correct Coding:
- Principal Dx: E11.22 β Type 2 DM with diabetic chronic kidney disease
- Additional: N18.4 β CKD Stage 4 (GFR 15-29) β CC
- Additional: I12.9 β Hypertensive CKD with stage 1-4 CKD
- Additional: D63.1 β Anemia in chronic kidney disease β CC
- Additional: Z79.84 β Long-term current use of oral hypoglycemic drugs
Sequencing: E11.22 is principal (condition chiefly responsible for admission β diabetic CKD management and nephrology workup); N18.4 is required companion; I12.9 is required for hypertension; D63.1 and Z79.84 are additional. N18.4 = CC β DRG 638.
CDI Note: D63.1 (anemia in CKD) is a CC-level code that reinforces DRG 638 β confirm the provider has documented the anemia as attributable to the CKD, not as iron deficiency or another etiology. A CDI query for anemia etiology documentation is appropriate if the record shows low hemoglobin/hematocrit without explicit provider linkage to CKD.
Scenario 3 β T2DM with ESRD, Dialysis-Dependent, HTN
A 74-year-old male with type 2 diabetes mellitus (insulin-dependent), ESRD secondary to diabetic kidney disease, hypertension, and dialysis dependence (thrice-weekly hemodialysis) was admitted for volume overload and heart failure exacerbation.
Correct Coding:
- Principal Dx: I50.9 β Heart failure, unspecified (or more specific if documented) β MCC
- Additional: E11.22 β Type 2 DM with diabetic chronic kidney disease
- Additional: N18.6 β End stage renal disease β MCC
- Additional: I12.0 β Hypertensive CKD with Stage 5 or ESRD
- Additional: Z99.2 β Dependence on renal dialysis
- Additional: Z79.4 β Long-term current use of insulin
Sequencing: I50.9 (or specific HF code β query for systolic vs. diastolic, acute vs. chronic) is principal because heart failure exacerbation was the reason for admission; E11.22 + N18.6 + I12.0 + Z99.2 are all required additional codes. I13.2 (hypertensive heart and CKD with HF and ESRD) may replace I12.0 + the separate HF code per ICD-10-CM combination code rules β query the provider and check guideline I.C.9.a for the I13.x applicability.
CDI Note: Highest-value CDI opportunity here is ensuring heart failure is specified as systolic vs. diastolic and acute vs. chronic (I50.21, I50.31, etc.) β the specific HF code carries higher MCC weight and strengthens clinical documentation. I13.2 as a single combination code replacing I12.0 + HF code is a coding efficiency and accuracy issue worth CDI team education.
β οΈ Coding Pitfalls and Tips
-
Omitting the required N18.x CKD stage code: E11.22 carries a Tabular βuse additional codeβ instruction requiring N18.1-N18.6 to identify the CKD stage. Assigning E11.22 without an N18.x companion code is non-compliant, incomplete, and misses the double HCC RAF capture opportunity (E11.22 β HCC 37 AND N18.x β HCC 328/329/326). This is the single most common and highest-impact coding omission in diabetic CKD encounters. Every E11.22 claim submission must include at least one N18.x code β if the CKD stage is not documented, query the provider before defaulting to N18.9 (unspecified CKD).
-
Assigning both E11.21 and E11.22 for the same encounter: The Excludes 1 relationship between E11.21 (diabetic nephropathy) and E11.22 (diabetic CKD) prohibits simultaneous assignment for the same patient encounter. This generates hard claim edits in most payer systems. When documentation contains both terms, assign the code that is more specific to what is documented β E11.22 is preferred when a CKD stage is documented; E11.21 is appropriate for documented proteinuric nephropathy without CKD staging. When genuinely ambiguous, query the provider.
-
Omitting I12.x or I13.x when hypertension is documented: When a patient has type 2 diabetes, CKD, and hypertension, ICD-10-CM guidelines I.C.9.a and I.C.4.a require E11.22 + N18.x + I12.x (or I13.x if heart failure is also present). Failing to add I12.x is one of the most common hypertensive CKD coding omissions and leaves a high-frequency, high-RAF code off the claim. The presumptive causal link between hypertension and CKD means no explicit βdue toβ documentation is needed β hypertension + CKD in the same record triggers I12.x.
-
Not adding Z79.4 or Z79.84 for diabetes medication use: The E11 category-level instruction requires an additional code to identify diabetes control method: Z79.4 (insulin), Z79.84 (oral hypoglycemic drugs), or both. These are frequently omitted in inpatient coding, particularly when the focus is on the CKD complication. While these codes do not independently drive HCC capture, they are required for complete and compliant coding and are captured by CMS for quality measurement purposes.
-
Coding from lab values alone for CKD stage: Coders cannot assign a specific N18.x stage code based solely on a GFR lab result in the chart β the provider must document the CKD stage in their clinical note, problem list, or discharge summary. When only lab values are present without provider staging documentation, a CDI query is mandatory. Many facilities have CDI triggers for GFR values consistent with advanced CKD (GFR < 30) to prompt provider stage documentation when it is absent.
-
Missing the I13.x opportunity when HF + HTN + CKD + DM are all present: When the patient has heart failure, hypertension, CKD, and diabetes all documented together, ICD-10-CM provides combination codes under I13.x (Hypertensive heart and chronic kidney disease) that capture the heart failure + hypertension + CKD linkage in a single code, replacing the need for separate I12.x + I50.xx codes. Coders unfamiliar with the I13.x combination codes frequently default to separate coding, which may be less precise. Guideline I.C.9.a governs this scenario β review it carefully when all four conditions are present.
Crystal's Coder Hub